JointHealth
français
ACE Arthritis Medications Report Card
Where does your province rank?

Advanced therapies such as biologics (originator and biosimilar) and targeted small molecule medications, deliver value both medically and socially. Used in a timely and appropriate fashion, these medications are life-changing; in some cases, life-saving. However, patients with inflammatory arthritis still have unmet medication needs. The gaps in treatment are a reflection of the fact that inflammatory arthritis is a complicated disease. It is a disease driven by many different biologic processes, so no single treatment is effective for every patient. In fact, a significant number of patients do not respond well or well enough to their initial, or second or third trialed, which underlines the need for continued discovery of other therapeutic targets.

Public drug plan policies at both the national, provincial, and territorial government levels are changing reimbursement access to treatment options for Canadians living with an inflammatory arthritis.

The Arthritis Consumer Experts (ACE) Arthritis Medications Report Card is designed to help Canadians evaluate where their province ranks in terms of providing reimbursement for medications approved for inflammatory arthritis such as rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis and juvenile idiopathic arthritis. The ACE Arthritis Medications Report Card tracks advanced therapy disease modifying anti-rheumatic drugs (or DMARDs) used to treat the most common types of inflammatory arthritis:
  • Biologic response modifier (originator or “boDMARD”)
  • Biologic response modifier (biosimilar or “bsDMARD”)
  • Targeted synthetic molecule (tsDMARD)
If your province doesn’t measure up, ACE encourages you to write and speak to your elected provincial or federal representative about the lack of equitable reimbursement access and patient/physician choice in treating inflammatory forms of arthritis.
1st : Ontario   (Last year: 1st)
generic name (Brand Name) rheumatoid arthritis axial spondyloarthritis juvenile arthritis psoriatic arthritis lupus vasculitis osteoporosis
ankylosing spondylitis non-radiographic axial spondyloarthritis (not visible on X-ray)
abatacept (Orencia®) Listed—CBC No NOC No NOC Listed—CBC No Info No NOC No NOC No NOC
adalimumab (Humira®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
adalimumab (Abrilada®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Amgevita®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hadlima®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hulio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hyrimoz®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Idacio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Simlandi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Yuflyma®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
anakinra (Kineret®) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC No NOC
anifrolumab (Saphnelo®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
belimumab (Benlysta®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
bimekizumab (Bimzelx®) No NOC Under Review No NOC No NOC Under Review No NOC No NOC No NOC
canakinumab (Ilaris®) No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC No NOC
certolizumab pegol (Cimzia®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
denosumab (Prolia®, boDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
denosumab (Jubbonti®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
etanercept (Enbrel®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
etanercept (Brenzys®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Erelzi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Rymti®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
golimumab (Simponi®) Listed—CBC Listed—CBC No Info No Info Listed—CBC No NOC No NOC No NOC
guselkumab (Tremfya®) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
infliximab (Remicade®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
infliximab (Avsola®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
infliximab (Inflectra®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
infliximab (Ixifi®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
infliximab (Renflexis®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
infliximab (Remsima®, bsDMARD) No Info No NOC No NOC No NOC No NOC No NOC No NOC No NOC
ixekizumab (Taltz®) No NOC Under Review No Info No NOC Listed—CBC No NOC No NOC No NOC
rituximab (Rituxan®, boDMARD) Not Reimbursed No NOC No NOC Not Reimbursed No NOC No NOC Not Reimbursed No NOC
rituximab (Riabni®, bsDMARD) No Info No NOC No NOC No Info No NOC No NOC Not Reimbursed No NOC
rituximab (Riximyo®, bsDMARD) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
rituximab (Ruxience®, bsDMARD) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
rituximab (Truxima®, bsDMARD) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
romosozumab (Evenity®) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
sarilumab (Kevzara®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
secukinumab (Cosentyx®) No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
tocilizumab (Actemra®) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
ustekinumab (Stelara®, boDMARD) No NOC No NOC No NOC No NOC Declined No NOC No NOC No NOC
ustekinumab (Jamteki®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
ustekinumab (Steqeyma®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
ustekinumab (Wezlana®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
apremilast (Otezla®)
Auro-Apremilast, Jamp Apremilast, Sandoz Apremilast
No NOC No NOC No NOC No NOC Declined No NOC No NOC No NOC
baricitinib (Olumiant®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
tofacitinib (Xeljanz®)
Auro-tofacitinib, Jamp tofacitinib, PMS-tofacitinib, Taro-tofacitinib
Listed—CBC No NOC No NOC No NOC No Info No NOC No NOC No NOC
upadacitinib (Rinvoq®) Listed—CBC No Info No NOC No NOC Listed—CBC No NOC No NOC No NOC
2nd : Québec   (Last year: 2nd)
generic name (Brand Name) rheumatoid arthritis axial spondyloarthritis juvenile arthritis psoriatic arthritis lupus vasculitis osteoporosis
ankylosing spondylitis non-radiographic axial spondyloarthritis (not visible on X-ray)
abatacept (Orencia®) Listed—CBC No NOC No NOC Listed—CBC Under Review No NOC No NOC No NOC
adalimumab (Humira®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
adalimumab (Abrilada®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Amgevita®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hadlima®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hulio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hyrimoz®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Idacio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Simlandi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Yuflyma®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
anakinra (Kineret®) Declined No NOC No NOC No NOC No NOC No NOC No NOC No NOC
anifrolumab (Saphnelo®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
belimumab (Benlysta®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
bimekizumab (Bimzelx®) No NOC Listed—CBC No NOC No NOC Under Review No NOC No NOC No NOC
canakinumab (Ilaris®) No NOC No NOC No NOC Under Review No NOC No NOC No NOC No NOC
certolizumab pegol (Cimzia®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
denosumab (Prolia®, boDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
denosumab (Jubbonti®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
etanercept (Enbrel®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
etanercept (Brenzys®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Erelzi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Rymti®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
golimumab (Simponi®) Listed—CBC Listed—CBC Under Review No Info Listed—CBC No NOC No NOC No NOC
guselkumab (Tremfya®) No NOC No NOC No NOC No NOC Declined No NOC No NOC No NOC
infliximab (Remicade®, boDMARD) Not Reimbursed Not Reimbursed No NOC Listed—CBC Not Reimbursed No NOC No NOC No NOC
infliximab (Avsola®, bsDMARD) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Inflectra®, bsDMARD) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Ixifi®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
infliximab (Renflexis®, bsDMARD) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Remsima®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
ixekizumab (Taltz®) No NOC Listed—CBC No Info No NOC Listed—CBC No NOC No NOC No NOC
rituximab (Rituxan®, boDMARD) Not Reimbursed No NOC No NOC No NOC No NOC No NOC Not Reimbursed No NOC
rituximab (Riabni®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Under Review No NOC
rituximab (Riximyo®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Ruxience®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Truxima®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
romosozumab (Evenity®) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
sarilumab (Kevzara®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
secukinumab (Cosentyx®) No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
tocilizumab (Actemra®) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
ustekinumab (Stelara®, boDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
ustekinumab (Jamteki®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
ustekinumab (Steqeyma®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
ustekinumab (Wezlana®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
apremilast (Otezla®)
Auro-Apremilast, Jamp Apremilast, Sandoz Apremilast
No NOC No NOC No NOC No NOC Declined No NOC No NOC No NOC
baricitinib (Olumiant®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
tofacitinib (Xeljanz®)
Auro-tofacitinib, Jamp tofacitinib, PMS-tofacitinib, Taro-tofacitinib
Listed—CBC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
upadacitinib (Rinvoq®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
3rd : New Brunswick   (Last year: 6th)
generic name (Brand Name) rheumatoid arthritis axial spondyloarthritis juvenile arthritis psoriatic arthritis lupus vasculitis osteoporosis
ankylosing spondylitis non-radiographic axial spondyloarthritis (not visible on X-ray)
abatacept (Orencia®) Listed—CBC No NOC No NOC Listed—CBC Under Review No NOC No NOC No NOC
adalimumab (Humira®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
adalimumab (Abrilada®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Amgevita®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hadlima®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hulio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hyrimoz®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Idacio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Simlandi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Yuflyma®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
anakinra (Kineret®) Under Review No NOC No NOC No NOC No NOC No NOC No NOC No NOC
anifrolumab (Saphnelo®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
belimumab (Benlysta®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
bimekizumab (Bimzelx®) No NOC Under Review No NOC No NOC Under Review No NOC No NOC No NOC
canakinumab (Ilaris®) No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC No NOC
certolizumab pegol (Cimzia®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
denosumab (Prolia®, boDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
denosumab (Jubbonti®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Under Review
etanercept (Enbrel®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
etanercept (Brenzys®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Erelzi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Rymti®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
golimumab (Simponi®) Listed—CBC Listed—CBC Under Review No Info Listed—CBC No NOC No NOC No NOC
guselkumab (Tremfya®) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Remicade®, boDMARD) Not Reimbursed Not Reimbursed No NOC No NOC Not Reimbursed No NOC No NOC No NOC
infliximab (Avsola®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Inflectra®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Ixifi®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
infliximab (Renflexis®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Remsima®, bsDMARD) Under Review No NOC No NOC No NOC No NOC No NOC No NOC No NOC
ixekizumab (Taltz®) No NOC Declined No Info No NOC Listed—CBC No NOC No NOC No NOC
rituximab (Rituxan®, boDMARD) Not Reimbursed No NOC No NOC No NOC No NOC No NOC Not Reimbursed No NOC
rituximab (Riabni®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Riximyo®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Ruxience®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Truxima®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
romosozumab (Evenity®) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
sarilumab (Kevzara®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
secukinumab (Cosentyx®) No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
tocilizumab (Actemra®) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
ustekinumab (Stelara®, boDMARD) No NOC No NOC No NOC No NOC Declined No NOC No NOC No NOC
ustekinumab (Jamteki®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
ustekinumab (Steqeyma®, bsDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Wezlana®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
apremilast (Otezla®)
Auro-Apremilast, Jamp Apremilast, Sandoz Apremilast
No NOC No NOC No NOC No NOC Declined No NOC No NOC No NOC
baricitinib (Olumiant®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
tofacitinib (Xeljanz®)
Auro-tofacitinib, Jamp tofacitinib, PMS-tofacitinib, Taro-tofacitinib
Listed—CBC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
upadacitinib (Rinvoq®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
4th : Manitoba   (Last year: 6th)
generic name (Brand Name) rheumatoid arthritis axial spondyloarthritis juvenile arthritis psoriatic arthritis lupus vasculitis osteoporosis
ankylosing spondylitis non-radiographic axial spondyloarthritis (not visible on X-ray)
abatacept (Orencia®) Listed—CBC No NOC No NOC No Info Under Review No NOC No NOC No NOC
adalimumab (Humira®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
adalimumab (Abrilada®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Amgevita®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hadlima®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hulio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hyrimoz®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Idacio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Simlandi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Yuflyma®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
anakinra (Kineret®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
anifrolumab (Saphnelo®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
belimumab (Benlysta®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
bimekizumab (Bimzelx®) No NOC Under Review No NOC No NOC Under Review No NOC No NOC No NOC
canakinumab (Ilaris®) No NOC No NOC No NOC Under Review No NOC No NOC No NOC No NOC
certolizumab pegol (Cimzia®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
denosumab (Prolia®, boDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
denosumab (Jubbonti®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
etanercept (Enbrel®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
etanercept (Brenzys®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Erelzi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Rymti®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
golimumab (Simponi®) Listed—CBC Listed—CBC No Info No Info Listed—CBC No NOC No NOC No NOC
guselkumab (Tremfya®) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Remicade®, boDMARD) Not Reimbursed Not Reimbursed No NOC No Info Not Reimbursed No NOC No NOC No NOC
infliximab (Avsola®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Inflectra®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Ixifi®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
infliximab (Renflexis®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Remsima®, bsDMARD) No Info No NOC No NOC No NOC No NOC No NOC No NOC No NOC
ixekizumab (Taltz®) No NOC Under Review No Info No NOC Listed—CBC No NOC No NOC No NOC
rituximab (Rituxan®, boDMARD) Not Reimbursed No NOC No NOC No NOC No NOC No NOC Not Reimbursed No NOC
rituximab (Riabni®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
rituximab (Riximyo®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Ruxience®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Truxima®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
romosozumab (Evenity®) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
sarilumab (Kevzara®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
secukinumab (Cosentyx®) No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
tocilizumab (Actemra®) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
ustekinumab (Stelara®, boDMARD) No NOC No NOC No NOC No NOC No Info No NOC No NOC No NOC
ustekinumab (Jamteki®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
ustekinumab (Steqeyma®, bsDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Wezlana®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
apremilast (Otezla®)
Auro-Apremilast, Jamp Apremilast, Sandoz Apremilast
No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
baricitinib (Olumiant®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
tofacitinib (Xeljanz®)
Auro-tofacitinib, Jamp tofacitinib, PMS-tofacitinib, Taro-tofacitinib
Listed—CBC No NOC No NOC No NOC No Info No NOC No NOC No NOC
upadacitinib (Rinvoq®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
4th : Nova Scotia   (Last year: 6th)
generic name (Brand Name) rheumatoid arthritis axial spondyloarthritis juvenile arthritis psoriatic arthritis lupus vasculitis osteoporosis
ankylosing spondylitis non-radiographic axial spondyloarthritis (not visible on X-ray)
abatacept (Orencia®) Listed—CBC No NOC No NOC Listed—CBC Under Review No NOC No NOC No NOC
adalimumab (Humira®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
adalimumab (Abrilada®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Amgevita®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hadlima®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hulio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hyrimoz®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Idacio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Simlandi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Yuflyma®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
anakinra (Kineret®) Under Review No NOC No NOC No NOC No NOC No NOC No NOC No NOC
anifrolumab (Saphnelo®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
belimumab (Benlysta®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
bimekizumab (Bimzelx®) No NOC Under Review No NOC No NOC Under Review No NOC No NOC No NOC
canakinumab (Ilaris®) No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC No NOC
certolizumab pegol (Cimzia®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
denosumab (Prolia®, boDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Not Reimbursed
denosumab (Jubbonti®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Not Reimbursed
etanercept (Enbrel®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
etanercept (Brenzys®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Erelzi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Rymti®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
golimumab (Simponi®) Listed—CBC Listed—CBC Under Review No Info Listed—CBC No NOC No NOC No NOC
guselkumab (Tremfya®) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Remicade®, boDMARD) Not Reimbursed Not Reimbursed No NOC No Info Not Reimbursed No NOC No NOC No NOC
infliximab (Avsola®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Inflectra®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Ixifi®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
infliximab (Renflexis®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Remsima®, bsDMARD) Under Review No NOC No NOC No NOC No NOC No NOC No NOC No NOC
ixekizumab (Taltz®) No NOC Under Review No Info No NOC Listed—CBC No NOC No NOC No NOC
rituximab (Rituxan®, boDMARD) Not Reimbursed No NOC No NOC No NOC No NOC No NOC Not Reimbursed No NOC
rituximab (Riabni®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Riximyo®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Ruxience®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Truxima®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
romosozumab (Evenity®) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
sarilumab (Kevzara®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
secukinumab (Cosentyx®) No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
tocilizumab (Actemra®) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
ustekinumab (Stelara®, boDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Jamteki®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
ustekinumab (Steqeyma®, bsDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Wezlana®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
apremilast (Otezla®)
Auro-Apremilast, Jamp Apremilast, Sandoz Apremilast
No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
baricitinib (Olumiant®) Under Review No NOC No NOC No NOC No NOC No NOC No NOC No NOC
tofacitinib (Xeljanz®)
Auro-tofacitinib, Jamp tofacitinib, PMS-tofacitinib, Taro-tofacitinib
Listed—CBC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
upadacitinib (Rinvoq®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
6th : Saskatchewan   (Last year: 5th)
generic name (Brand Name) rheumatoid arthritis axial spondyloarthritis juvenile arthritis psoriatic arthritis lupus vasculitis osteoporosis
ankylosing spondylitis non-radiographic axial spondyloarthritis (not visible on X-ray)
abatacept (Orencia®) Listed—CBC No NOC No NOC Listed—CBC No Info No NOC No NOC No NOC
adalimumab (Humira®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
adalimumab (Abrilada®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Amgevita®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hadlima®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hulio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hyrimoz®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Idacio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Simlandi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Yuflyma®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
anakinra (Kineret®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
anifrolumab (Saphnelo®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
belimumab (Benlysta®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
bimekizumab (Bimzelx®) No NOC Under Review No NOC No NOC Under Review No NOC No NOC No NOC
canakinumab (Ilaris®) No NOC No NOC No NOC Declined No NOC No NOC No NOC No NOC
certolizumab pegol (Cimzia®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
denosumab (Prolia®, boDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
denosumab (Jubbonti®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Under Review
etanercept (Enbrel®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
etanercept (Brenzys®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Erelzi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Rymti®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
golimumab (Simponi®) Listed—CBC Listed—CBC No Info No Info Listed—CBC No NOC No NOC No NOC
guselkumab (Tremfya®) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Remicade®, boDMARD) Not Reimbursed Not Reimbursed No NOC No Info Not Reimbursed No NOC No NOC No NOC
infliximab (Avsola®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Inflectra®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Ixifi®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
infliximab (Renflexis®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Remsima®, bsDMARD) Declined No NOC No NOC No NOC No NOC No NOC No NOC No NOC
ixekizumab (Taltz®) No NOC No Info No Info No NOC Listed—CBC No NOC No NOC No NOC
rituximab (Rituxan®, boDMARD) Not Reimbursed No NOC No NOC No NOC No NOC No NOC Not Reimbursed No NOC
rituximab (Riabni®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
rituximab (Riximyo®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Ruxience®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Truxima®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
romosozumab (Evenity®) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
sarilumab (Kevzara®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
secukinumab (Cosentyx®) No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
tocilizumab (Actemra®) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
ustekinumab (Stelara®, boDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
ustekinumab (Jamteki®, bsDMARD) No NOC No NOC No NOC No NOC No Info No NOC No NOC No NOC
ustekinumab (Steqeyma®, bsDMARD) No NOC No NOC No NOC No NOC No Info No NOC No NOC No NOC
ustekinumab (Wezlana®, bsDMARD) No NOC No NOC No NOC No NOC No Info No NOC No NOC No NOC
apremilast (Otezla®)
Auro-Apremilast, Jamp Apremilast, Sandoz Apremilast
No NOC No NOC No NOC No NOC Declined No NOC No NOC No NOC
baricitinib (Olumiant®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
tofacitinib (Xeljanz®)
Auro-tofacitinib, Jamp tofacitinib, PMS-tofacitinib, Taro-tofacitinib
Listed—CBC No NOC No NOC No NOC No Info No NOC No NOC No NOC
upadacitinib (Rinvoq®) Listed—CBC No Info No NOC No NOC Listed—CBC No NOC No NOC No NOC
7th : Alberta   (Last year :3rd)
generic name (Brand Name) rheumatoid arthritis axial spondyloarthritis juvenile arthritis psoriatic arthritis lupus vasculitis osteoporosis
ankylosing spondylitis non-radiographic axial spondyloarthritis (not visible on X-ray)
abatacept (Orencia®) Listed—CBC No NOC No NOC Listed—CBC No Info No NOC No NOC No NOC
adalimumab (Humira®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
adalimumab (Abrilada®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Amgevita®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hadlima®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hulio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hyrimoz®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Idacio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Simlandi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Yuflyma®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
anakinra (Kineret®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
anifrolumab (Saphnelo®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
belimumab (Benlysta®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
bimekizumab (Bimzelx®) No NOC Under Review No NOC No NOC Under Review No NOC No NOC No NOC
canakinumab (Ilaris®) No NOC No NOC No NOC Declined No NOC No NOC No NOC No NOC
certolizumab pegol (Cimzia®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
denosumab (Prolia®, boDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
denosumab (Jubbonti®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Under Review
etanercept (Enbrel®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
etanercept (Brenzys®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Erelzi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Rymti®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
golimumab (Simponi®) Listed—CBC Listed—CBC No Info No Info Listed—CBC No NOC No NOC No NOC
guselkumab (Tremfya®) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Remicade®, boDMARD) Not Reimbursed Not Reimbursed No NOC No NOC Not Reimbursed No NOC No NOC No NOC
infliximab (Avsola®, bsDMARD) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Inflectra®, bsDMARD) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Ixifi®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
infliximab (Renflexis®, bsDMARD) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Remsima®, bsDMARD) No Info No NOC No NOC No NOC No NOC No NOC No NOC No NOC
ixekizumab (Taltz®) No NOC Under Review No Info No NOC Listed—CBC No NOC No NOC No NOC
rituximab (Rituxan®, boDMARD) Not Reimbursed No NOC No NOC No NOC No NOC No NOC Not Reimbursed No NOC
rituximab (Riabni®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
rituximab (Riximyo®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Ruxience®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Truxima®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
romosozumab (Evenity®) No NOC No NOC No NOC No NOC No NOC No NOC No NOC No Info
sarilumab (Kevzara®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
secukinumab (Cosentyx®) No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
tocilizumab (Actemra®) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
ustekinumab (Stelara®, boDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Jamteki®, bsDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Steqeyma®, bsDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Wezlana®, bsDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
apremilast (Otezla®)
Auro-Apremilast, Jamp Apremilast, Sandoz Apremilast
No NOC No NOC No NOC No NOC Declined No NOC No NOC No NOC
baricitinib (Olumiant®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
tofacitinib (Xeljanz®)
Auro-tofacitinib, Jamp tofacitinib, PMS-tofacitinib, Taro-tofacitinib
Listed—CBC No NOC No NOC No NOC No Info No NOC No NOC No NOC
upadacitinib (Rinvoq®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
8th : NIHB*   (Last year: 11th)
generic name (Brand Name) rheumatoid arthritis axial spondyloarthritis juvenile arthritis psoriatic arthritis lupus vasculitis osteoporosis
ankylosing spondylitis non-radiographic axial spondyloarthritis (not visible on X-ray)
abatacept (Orencia®) Listed—CBC No NOC No NOC Listed—CBC Under Review No NOC No NOC No NOC
adalimumab (Humira®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
adalimumab (Abrilada®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Amgevita®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hadlima®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hulio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hyrimoz®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Idacio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Simlandi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Yuflyma®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
anakinra (Kineret®) Declined No NOC No NOC No NOC No NOC No NOC No NOC No NOC
anifrolumab (Saphnelo®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
belimumab (Benlysta®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
bimekizumab (Bimzelx®) No NOC Under Review No NOC No NOC Under Review No NOC No NOC No NOC
canakinumab (Ilaris®) No NOC No NOC No NOC Under Review No NOC No NOC No NOC No NOC
certolizumab pegol (Cimzia®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
denosumab (Prolia®, boDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
denosumab (Jubbonti®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Under Review
etanercept (Enbrel®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
etanercept (Brenzys®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Erelzi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Rymti®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
golimumab (Simponi®) Listed—CBC Listed—CBC Under Review No Info Listed—CBC No NOC No NOC No NOC
guselkumab (Tremfya®) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Remicade®, boDMARD) Not Reimbursed Declined No NOC No NOC Declined No NOC No NOC No NOC
infliximab (Avsola®, bsDMARD) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Inflectra®, bsDMARD) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Ixifi®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
infliximab (Renflexis®, bsDMARD) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Remsima®, bsDMARD) Under Review No NOC No NOC No NOC No NOC No NOC No NOC No NOC
ixekizumab (Taltz®) No NOC No NOC No Info No NOC Listed—CBC No NOC No NOC No NOC
rituximab (Rituxan®, boDMARD) Not Reimbursed No NOC No NOC No NOC No NOC No NOC Not Reimbursed No NOC
rituximab (Riabni®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Riximyo®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Ruxience®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Truxima®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
romosozumab (Evenity®) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
sarilumab (Kevzara®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
secukinumab (Cosentyx®) No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
tocilizumab (Actemra®) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
ustekinumab (Stelara®, boDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Jamteki®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
ustekinumab (Steqeyma®, bsDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Wezlana®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
apremilast (Otezla®)
Auro-Apremilast, Jamp Apremilast, Sandoz Apremilast
No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
baricitinib (Olumiant®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
tofacitinib (Xeljanz®)
Auro-tofacitinib, Jamp tofacitinib, PMS-tofacitinib, Taro-tofacitinib
Listed—CBC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
upadacitinib (Rinvoq®) Listed—CBC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
9th : Prince Edward Island   (Last year: 10th)
generic name (Brand Name) rheumatoid arthritis axial spondyloarthritis juvenile arthritis psoriatic arthritis lupus vasculitis osteoporosis
ankylosing spondylitis non-radiographic axial spondyloarthritis (not visible on X-ray)
abatacept (Orencia®) Listed—CBC No NOC No NOC Listed—CBC Under Review No NOC No NOC No NOC
adalimumab (Humira®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
adalimumab (Abrilada®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Amgevita®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hadlima®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hulio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hyrimoz®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Idacio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Simlandi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Yuflyma®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
anakinra (Kineret®) Under Review No NOC No NOC No NOC No NOC No NOC No NOC No NOC
anifrolumab (Saphnelo®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
belimumab (Benlysta®) No NOC No NOC No NOC No NOC No NOC Under Review No NOC No NOC
bimekizumab (Bimzelx®) No NOC Under Review No NOC No NOC Under Review No NOC No NOC No NOC
canakinumab (Ilaris®) No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC No NOC
certolizumab pegol (Cimzia®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
denosumab (Prolia®, boDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
denosumab (Jubbonti®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Under Review
etanercept (Enbrel®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
etanercept (Brenzys®, bsDMARD) Listed—CBC Listed—CBC No NOC Under Review Listed—CBC No NOC No NOC No NOC
etanercept (Erelzi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Rymti®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
golimumab (Simponi®) Listed—CBC Listed—CBC Under Review No Info Listed—CBC No NOC No NOC No NOC
guselkumab (Tremfya®) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Remicade®, boDMARD) Not Reimbursed Not Reimbursed No NOC No NOC Not Reimbursed No NOC No NOC No NOC
infliximab (Avsola®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Inflectra®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Ixifi®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
infliximab (Renflexis®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Remsima®, bsDMARD) Under Review No NOC No NOC No NOC No NOC No NOC No NOC No NOC
ixekizumab (Taltz®) No NOC Under Review No Info No NOC Listed—CBC No NOC No NOC No NOC
rituximab (Rituxan®, boDMARD) Not Reimbursed No NOC No NOC No NOC No NOC No NOC Not Reimbursed No NOC
rituximab (Riabni®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Riximyo®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Ruxience®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Truxima®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
romosozumab (Evenity®) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Under Review
sarilumab (Kevzara®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
secukinumab (Cosentyx®) No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
tocilizumab (Actemra®) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
ustekinumab (Stelara®, boDMARD) No NOC No NOC No NOC No NOC Not Reimbursed No NOC No NOC No NOC
ustekinumab (Jamteki®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
ustekinumab (Steqeyma®, bsDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Wezlana®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
apremilast (Otezla®)
Auro-Apremilast, Jamp Apremilast, Sandoz Apremilast
No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
baricitinib (Olumiant®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
tofacitinib (Xeljanz®)
Auro-tofacitinib, Jamp tofacitinib, PMS-tofacitinib, Taro-tofacitinib
Listed—CBC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
upadacitinib (Rinvoq®) Listed—CBC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
10th : British Columbia   (Last year: 3rd)
generic name (Brand Name) rheumatoid arthritis axial spondyloarthritis juvenile arthritis psoriatic arthritis lupus vasculitis osteoporosis
ankylosing spondylitis non-radiographic axial spondyloarthritis (not visible on X-ray)
abatacept (Orencia®) Listed—CBC No NOC No NOC Listed—CBC No Info No NOC No NOC No NOC
adalimumab (Humira®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
adalimumab (Abrilada®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Amgevita®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hadlima®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hulio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hyrimoz®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Idacio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Simlandi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Yuflyma®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
anakinra (Kineret®) Declined No NOC No NOC No NOC No NOC No NOC No NOC No NOC
anifrolumab (Saphnelo®) No NOC No NOC No NOC No NOC No NOC Under Review No NOC No NOC
belimumab (Benlysta®) No NOC No NOC No NOC No NOC No NOC Under Review No NOC No NOC
bimekizumab (Bimzelx®) No NOC Under Review No NOC No NOC Under Review No NOC No NOC No NOC
canakinumab (Ilaris®) No NOC No NOC No NOC Declined No NOC No NOC No NOC No NOC
certolizumab pegol (Cimzia®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
denosumab (Prolia®, boDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Not Reimbursed
denosumab (Jubbonti®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
etanercept (Enbrel®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
etanercept (Brenzys®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Erelzi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Rymti®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
golimumab (Simponi®) Listed—CBC Listed—CBC Under Review No Info Listed—CBC No NOC No NOC No NOC
guselkumab (Tremfya®) No NOC No NOC No NOC No NOC Declined No NOC No NOC No NOC
infliximab (Remicade®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
infliximab (Avsola®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Inflectra®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Ixifi®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
infliximab (Renflexis®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Remsima®, bsDMARD) Declined No NOC No NOC No NOC No NOC No NOC No NOC No NOC
ixekizumab (Taltz®) No NOC Declined No Info No NOC Listed—CBC No NOC No NOC No NOC
rituximab (Rituxan®, boDMARD) Not Reimbursed No NOC No NOC No NOC No NOC No NOC Not Reimbursed No NOC
rituximab (Riabni®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
rituximab (Riximyo®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Ruxience®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Truxima®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
romosozumab (Evenity®) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
sarilumab (Kevzara®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
secukinumab (Cosentyx®) No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
tocilizumab (Actemra®) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
ustekinumab (Stelara®, boDMARD) No NOC No NOC No NOC No NOC Not Reimbursed No NOC No NOC No NOC
ustekinumab (Jamteki®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
ustekinumab (Steqeyma®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
ustekinumab (Wezlana®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
apremilast (Otezla®)
Auro-Apremilast, Jamp Apremilast, Sandoz Apremilast
No NOC No NOC No NOC No NOC Declined No NOC No NOC No NOC
baricitinib (Olumiant®) Declined No NOC No NOC No NOC No NOC No NOC No NOC No NOC
tofacitinib (Xeljanz®)
Auro-tofacitinib, Jamp tofacitinib, PMS-tofacitinib, Taro-tofacitinib
Listed—CBC No NOC No NOC No NOC No Info No NOC No NOC No NOC
upadacitinib (Rinvoq®) Declined Under Review No NOC No NOC Declined No NOC No NOC No NOC
11th : Newfoundland and Labrador   (Last year: 9th)
generic name (Brand Name) rheumatoid arthritis axial spondyloarthritis juvenile arthritis psoriatic arthritis lupus vasculitis osteoporosis
ankylosing spondylitis non-radiographic axial spondyloarthritis (not visible on X-ray)
abatacept (Orencia®) Listed—CBC No NOC No NOC Listed—CBC Under Review No NOC No NOC No NOC
adalimumab (Humira®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
adalimumab (Abrilada®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Amgevita®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hadlima®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hulio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hyrimoz®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Idacio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Simlandi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Yuflyma®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
anakinra (Kineret®) Under Review No NOC No NOC No NOC No NOC No NOC No NOC No NOC
anifrolumab (Saphnelo®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
belimumab (Benlysta®) No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC
bimekizumab (Bimzelx®) No NOC Under Review No NOC No NOC Under Review No NOC No NOC No NOC
canakinumab (Ilaris®) No NOC No NOC No NOC Under Review No NOC No NOC No NOC No NOC
certolizumab pegol (Cimzia®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
denosumab (Prolia®, boDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Not Reimbursed
denosumab (Jubbonti®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
etanercept (Enbrel®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
etanercept (Brenzys®, bsDMARD) Listed—CBC Listed—CBC No NOC Under Review Under Review No NOC No NOC No NOC
etanercept (Erelzi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Rymti®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
golimumab (Simponi®) Listed—CBC Listed—CBC Under Review No Info Listed—CBC No NOC No NOC No NOC
guselkumab (Tremfya®) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Remicade®, boDMARD) Not Reimbursed Not Reimbursed No NOC No Info Not Reimbursed No NOC No NOC No NOC
infliximab (Avsola®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Inflectra®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Ixifi®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
infliximab (Renflexis®, bsDMARD) Listed—CBC Listed—CBC No NOC No Info Listed—CBC No NOC No NOC No NOC
infliximab (Remsima®, bsDMARD) Under Review No NOC No NOC No NOC No NOC No NOC No NOC No NOC
ixekizumab (Taltz®) No NOC Under Review No Info No NOC Listed—CBC No NOC No NOC No NOC
rituximab (Rituxan®, boDMARD) Not Reimbursed No NOC No NOC No NOC No NOC No NOC Not Reimbursed No NOC
rituximab (Riabni®, bsDMARD) Under Review No NOC No NOC No NOC No NOC No NOC Under Review No NOC
rituximab (Riximyo®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Ruxience®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Truxima®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
romosozumab (Evenity®) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
sarilumab (Kevzara®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
secukinumab (Cosentyx®) No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
tocilizumab (Actemra®) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
ustekinumab (Stelara®, boDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Jamteki®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
ustekinumab (Steqeyma®, bsDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Wezlana®, bsDMARD) No NOC No NOC No NOC No NOC Listed—CBC No NOC No NOC No NOC
apremilast (Otezla®)
Auro-Apremilast, Jamp Apremilast, Sandoz Apremilast
No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
baricitinib (Olumiant®) Under Review No NOC No NOC No NOC No NOC No NOC No NOC No NOC
tofacitinib (Xeljanz®)
Auro-tofacitinib, Jamp tofacitinib, PMS-tofacitinib, Taro-tofacitinib
Listed—CBC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
upadacitinib (Rinvoq®) Listed—CBC No Info No NOC No NOC Listed—CBC No NOC No NOC No NOC
12th : Northwest Territories   N/A
generic name (Brand Name) rheumatoid arthritis axial spondyloarthritis juvenile arthritis psoriatic arthritis lupus vasculitis osteoporosis
ankylosing spondylitis non-radiographic axial spondyloarthritis (not visible on X-ray)
abatacept (Orencia®) Listed—CBC No NOC No NOC Listed—CBC Under Review No NOC No NOC No NOC
adalimumab (Humira®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
adalimumab (Abrilada®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Amgevita®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hadlima®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hulio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hyrimoz®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Idacio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Simlandi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Yuflyma®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
anakinra (Kineret®) Declined No NOC No NOC No NOC No NOC No NOC No NOC No NOC
anifrolumab (Saphnelo®) No NOC No NOC No NOC No NOC No NOC Under Review No NOC No NOC
belimumab (Benlysta®) No NOC No NOC No NOC No NOC No NOC Declined No NOC No NOC
bimekizumab (Bimzelx®) No NOC Under Review No NOC No NOC Under Review No NOC No NOC No NOC
canakinumab (Ilaris®) No NOC No NOC No NOC Under Review No NOC No NOC No NOC No NOC
certolizumab pegol (Cimzia®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
denosumab (Prolia®, boDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
denosumab (Jubbonti®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Under Review
etanercept (Enbrel®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
etanercept (Brenzys®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Erelzi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Rymti®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
golimumab (Simponi®) Listed—CBC Listed—CBC Under Review No Info Listed—CBC No NOC No NOC No NOC
guselkumab (Tremfya®) No NOC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
infliximab (Remicade®, boDMARD) Not Reimbursed Not Reimbursed No NOC No Info Not Reimbursed No NOC No NOC No NOC
infliximab (Avsola®, bsDMARD) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Inflectra®, bsDMARD) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Ixifi®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
infliximab (Renflexis®, bsDMARD) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Remsima®, bsDMARD) Declined No NOC No NOC No NOC No NOC No NOC No NOC No NOC
ixekizumab (Taltz®) No NOC Under Review No Info No NOC Listed—CBC No NOC No NOC No NOC
rituximab (Rituxan®, boDMARD) Not Reimbursed No NOC No NOC No NOC No NOC No NOC Not Reimbursed No NOC
rituximab (Riabni®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Riximyo®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Ruxience®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Truxima®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
romosozumab (Evenity®) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Under Review
sarilumab (Kevzara®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
secukinumab (Cosentyx®) No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
tocilizumab (Actemra®) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
ustekinumab (Stelara®, boDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Jamteki®, bsDMARD) No NOC No NOC No NOC No NOC No Info No NOC No NOC No NOC
ustekinumab (Steqeyma®, bsDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Wezlana®, bsDMARD) No NOC No NOC No NOC No NOC No Info No NOC No NOC No NOC
apremilast (Otezla®)
Auro-Apremilast, Jamp Apremilast, Sandoz Apremilast
No NOC No NOC No NOC No NOC Declined No NOC No NOC No NOC
baricitinib (Olumiant®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
tofacitinib (Xeljanz®)
Auro-tofacitinib, Jamp tofacitinib, PMS-tofacitinib, Taro-tofacitinib
Listed—CBC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
upadacitinib (Rinvoq®) Under Review No NOC No NOC No NOC Under Review No NOC No NOC No NOC
13th : Yukon   (Last year: 12th)
generic name (Brand Name) rheumatoid arthritis axial spondyloarthritis juvenile arthritis psoriatic arthritis lupus vasculitis osteoporosis
ankylosing spondylitis non-radiographic axial spondyloarthritis (not visible on X-ray)
abatacept (Orencia®) Listed—CBC No NOC No NOC Under Review Under Review No NOC No NOC No NOC
adalimumab (Humira®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
adalimumab (Abrilada®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Amgevita®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hadlima®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hulio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Hyrimoz®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Idacio®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Simlandi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
adalimumab (Yuflyma®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
anakinra (Kineret®) Listed—CBC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
anifrolumab (Saphnelo®) No NOC No NOC No NOC No NOC No NOC Under Review No NOC No NOC
belimumab (Benlysta®) No NOC No NOC No NOC No NOC No NOC Under Review No NOC No NOC
bimekizumab (Bimzelx®) No NOC Under Review No NOC No NOC Under Review No NOC No NOC No NOC
canakinumab (Ilaris®) No NOC No NOC No NOC Under Review No NOC No NOC No NOC No NOC
certolizumab pegol (Cimzia®) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
denosumab (Prolia®, boDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Listed—CBC
denosumab (Jubbonti®, bsDMARD) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Under Review
etanercept (Enbrel®, boDMARD) Not Reimbursed Not Reimbursed No NOC Not Reimbursed Not Reimbursed No NOC No NOC No NOC
etanercept (Brenzys®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Erelzi®, bsDMARD) Listed—CBC Listed—CBC No NOC Listed—CBC Listed—CBC No NOC No NOC No NOC
etanercept (Rymti®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
golimumab (Simponi®) Listed—CBC Listed—CBC Under Review No Info Listed—CBC No NOC No NOC No NOC
guselkumab (Tremfya®) No NOC No NOC No NOC No NOC No NOC No NOC No NOC No NOC
infliximab (Remicade®, boDMARD) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Avsola®, bsDMARD) Under Review Under Review No NOC No NOC Under Review No NOC No NOC No NOC
infliximab (Inflectra®, bsDMARD) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Ixifi®, bsDMARD) No Info No Info No NOC No Info No Info No NOC No NOC No NOC
infliximab (Renflexis®, bsDMARD) Listed—CBC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
infliximab (Remsima®, bsDMARD) Under Review No NOC No NOC No NOC No NOC No NOC No NOC No NOC
ixekizumab (Taltz®) No NOC Under Review No Info No NOC Listed—CBC No NOC No NOC No NOC
rituximab (Rituxan®, boDMARD) Not Reimbursed No NOC No NOC No NOC No NOC No NOC Not Reimbursed No NOC
rituximab (Riabni®, bsDMARD) Under Review No NOC No NOC No NOC No NOC No NOC Under Review No NOC
rituximab (Riximyo®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Ruxience®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
rituximab (Truxima®, bsDMARD) Listed—CBC No NOC No NOC No NOC No NOC No NOC Listed—CBC No NOC
romosozumab (Evenity®) No NOC No NOC No NOC No NOC No NOC No NOC No NOC Under Review
sarilumab (Kevzara®) Under Review No NOC No NOC No NOC No NOC No NOC No NOC No NOC
secukinumab (Cosentyx®) No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC No NOC
tocilizumab (Actemra®) Listed—CBC No NOC No NOC Listed—CBC No NOC No NOC Listed—CBC No NOC
ustekinumab (Stelara®, boDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Jamteki®, bsDMARD) No NOC No NOC No NOC No NOC No Info No NOC No NOC No NOC
ustekinumab (Steqeyma®, bsDMARD) No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
ustekinumab (Wezlana®, bsDMARD) No NOC No NOC No NOC No NOC No Info No NOC No NOC No NOC
apremilast (Otezla®)
Auro-Apremilast, Jamp Apremilast, Sandoz Apremilast
No NOC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
baricitinib (Olumiant®) Under Review No NOC No NOC No NOC No NOC No NOC No NOC No NOC
tofacitinib (Xeljanz®)
Auro-tofacitinib, Jamp tofacitinib, PMS-tofacitinib, Taro-tofacitinib
Listed—CBC No NOC No NOC No NOC Under Review No NOC No NOC No NOC
upadacitinib (Rinvoq®) Under Review No NOC No NOC No NOC No NOC No NOC No NOC No NOC

About the report card:
Arthritis Consumer Experts graded each of the provinces by assigning a score based upon number of medications listed, number under review, and number of declined listings. Because provincial formularies change frequently, we encourage you to contact the Ministry of Health in your province with questions you may have about medication listings of concern to you.

Definitions

Declined: The formulary does not reimburse patients prescribed this medication. The BC Drug Formulary uses the term “non-benefit”.
Listed—CBC: Each province and territory has a process by which medications that are not normally included in the provincial, territorial or federal drug benefit lists are covered (or reimbursed). Approval of this drug is granted on a case-by-case basis.
Listed—ORC: The medication is listed, but the criteria are not supported by medical evidence. Arthritis Consumer Experts considers these overly restrictive criteria (ORC) unacceptable.
No NOC: No Notice of Compliance (or NOC) has been issued for this medication for this form of arthritis.
Under Review: This drug has been approved by Health Canada for this disease type and the publicly funded drug plan is considering whether patients should be reimbursed for it.
No Info: (No Information) The publicly funded drug plan has not provided information on status of medication reimbursement listing.
Delisted: The formulary has delisted the originator biologic.


* Note: The Non-Insured Health Benefits (NHIB) program provides supplementary health benefits, including prescription and non-prescription drugs, for registered First Nations and recognized Inuit throughout Canada.

Disclaimer: The material contained in this or any other ACE publication is provided for general information only. It should not be relied on to suggest a course of treatment for a particular individual or as a substitute for consultation with qualified health professionals who are familiar with your individual medical needs. If you have any healthcare related questions or concerns, you should contact your physician. Never disregard medical advice or delay in seeking it because of something you have read in any ACE publication.